)
Edge29 May 2026
Who You Gonna Call? The Story of Rollins
How Rollins built one of America's most consistent businesses through recurring pest control, trusted local brands, and decades of acquisitions.
Balaxi Pharmaceuticals
Balaxi Pharmaceuticals (BALAXI) investor relations material
Balaxi Pharmaceuticals Q4 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 25/26 earnings summary28 May, 2026
Executive summary
Approved audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026, with unmodified audit opinions from statutory auditors.
Re-appointed internal auditors and recommended re-appointment of an independent director for a second term.
Noted successful commissioning and licensing of the first pharmaceutical formulation plant at Jadcherla, Hyderabad, with commercialization of initial products imminent.
Scheduled the 83rd Annual General Meeting for August 24, 2026.
Financial highlights
Standalone revenue from operations for FY26 was ₹8,085.11 lakhs, up from ₹6,098.82 lakhs in FY25.
Standalone net profit for FY26 was ₹514.69 lakhs, compared to a net loss of ₹117.85 lakhs in FY25.
Consolidated revenue from operations for FY26 was ₹27,017.35 lakhs, compared to ₹29,256.12 lakhs in FY25.
Consolidated net profit for FY26 was ₹2,507.02 lakhs, up from ₹2,766.80 lakhs in FY25.
Earnings per share (EPS) for FY26: Standalone ₹0.93, Consolidated ₹4.54.
Outlook and guidance
The company is prepared for commercial manufacturing of Paracetamol Tablet 500mg and Piroxicam Capsule 20mg.
Initiated process for manufacturing permissions for 40 additional products, supporting phased expansion.
Progressing towards WHO-GMP certification to strengthen manufacturing capabilities and future growth.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Balaxi Pharmaceuticals
- Q3 FY26 revenue rose sequentially, margins were pressured, and the new plant is inspection-ready.BALAXI
Q3 25/2630 Jan 2026 - Margins improved and profitability returned as a USD 5M Dubai investment supports expansion.BALAXIQ1 24/2520 Nov 2025
- Q2 FY25 revenue surged 41% YoY, but PAT dropped 68% amid margin pressures.BALAXIQ2 24/2520 Nov 2025
- Revenue and profit declined, but manufacturing expansion and Dubai investment support future growth.BALAXIQ2 25/2614 Nov 2025
- Revenue up 21% year-over-year, net profit more than doubled, new plant validation underway.BALAXIQ4 24/2511 Aug 2025
- Revenue and profit rose year-over-year, with new plant operations to start in September 2025.BALAXIQ1 25/2611 Aug 2025
- Revenue rose but margins fell; Hyderabad plant to boost future growth.BALAXIQ3 20256 Jun 2025
Next Balaxi Pharmaceuticals earnings date
Q1 26/274 Aug, 2026
Balaxi Pharmaceuticals
Next Balaxi Pharmaceuticals earnings date
Q1 26/274 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage